Literature DB >> 9616501

Ticlopidine-induced severe neutropenia.

H Gur1, R Wartenfeld, D Tanne, F Solomon, Y Sidi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9616501      PMCID： PMC2360817          DOI： 10.1136/pgmj.74.868.126

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  8 in total

Review 1.  Granulocyte colony-stimulating factor for neutropenia secondary to ticlopidine.

Authors:  G Ruiz-Irastorza; J J Alonso; J J Iglesias; C Aguirre
Journal:  Acta Haematol       Date:  1994       Impact factor: 2.195

2.  Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group.

Authors:  F Balsano; P Rizzon; F Violi; D Scrutinio; C Cimminiello; F Aguglia; C Pasotti; G Rudelli
Journal:  Circulation       Date:  1990-07       Impact factor: 29.690

Review 3.  Ticlopidine: a new platelet aggregation inhibitor.

Authors:  M K Ito; A R Smith; M L Lee
Journal:  Clin Pharm       Date:  1992-07

4.  A critical appraisal of ticlopidine, a new antiplatelet agent. Effectiveness and clinical indications for prophylaxis of atherosclerotic events.

Authors:  R B Haynes; R S Sandler; E B Larson; J L Pater; F M Yatsu
Journal:  Arch Intern Med       Date:  1992-07

5.  The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.

Authors:  M Gent; J A Blakely; J D Easton; D J Ellis; V C Hachinski; J W Harbison; E Panak; R S Roberts; J Sicurella; A G Turpie
Journal:  Lancet       Date:  1989-06-03       Impact factor: 79.321

6.  A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group.

Authors:  W K Hass; J D Easton; H P Adams; W Pryse-Phillips; B A Molony; S Anderson; B Kamm
Journal:  N Engl J Med       Date:  1989-08-24       Impact factor: 91.245

7.  Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study.

Authors:  A Bellavance
Journal:  Stroke       Date:  1993-10       Impact factor: 7.914

8.  Ticlopidine versus aspirin for the prevention of recurrent stroke. Analysis of patients with minor stroke from the Ticlopidine Aspirin Stroke Study.

Authors:  J W Harbison
Journal:  Stroke       Date:  1992-12       Impact factor: 7.914
  8 in total
  1 in total

Review 1.  A Review of Antiplatelet Activity of Traditional Medicinal Herbs on Integrative Medicine Studies.

Authors:  Kyungho Kim; Kwang-Il Park
Journal:  Evid Based Complement Alternat Med       Date:  2019-01-03       Impact factor: 2.629
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.